Your browser doesn't support javascript.
Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections.
Illingworth, Christopher Jr; Hamilton, William L; Warne, Ben; Routledge, Matthew; Popay, Ashley; Jackson, Chris; Fieldman, Tom; Meredith, Luke W; Houldcroft, Charlotte J; Hosmillo, Myra; Jahun, Aminu S; Caller, Laura G; Caddy, Sarah L; Yakovleva, Anna; Hall, Grant; Khokhar, Fahad A; Feltwell, Theresa; Pinckert, Malte L; Georgana, Iliana; Chaudhry, Yasmin; Curran, Martin D; Parmar, Surendra; Sparkes, Dominic; Rivett, Lucy; Jones, Nick K; Sridhar, Sushmita; Forrest, Sally; Dymond, Tom; Grainger, Kayleigh; Workman, Chris; Ferris, Mark; Gkrania-Klotsas, Effrossyni; Brown, Nicholas M; Weekes, Michael P; Baker, Stephen; Peacock, Sharon J; Goodfellow, Ian G; Gouliouris, Theodore; de Angelis, Daniela; Török, M Estée.
  • Illingworth CJ; MRC Biostatistics Unit, University of Cambridge, East Forvie Building, Forvie Site, Robinson Way, Cambridge, United Kingdom.
  • Hamilton WL; Institut für Biologische Physik, Universität zu Köln, Köln, Germany.
  • Warne B; Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, Cambridge, United States.
  • Routledge M; University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Popay A; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Jackson C; University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Fieldman T; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Meredith LW; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Houldcroft CJ; Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Hosmillo M; Public Health England Field Epidemiology Unit, Cambridge Institute of Public Health, Forvie Site, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Jahun AS; MRC Biostatistics Unit, University of Cambridge, East Forvie Building, Forvie Site, Robinson Way, Cambridge, United Kingdom.
  • Caller LG; University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Caddy SL; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Yakovleva A; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Hall G; University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Khokhar FA; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Feltwell T; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Pinckert ML; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Georgana I; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom.
  • Chaudhry Y; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Curran MD; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Parmar S; University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Sparkes D; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom.
  • Rivett L; University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Jones NK; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Sridhar S; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Forrest S; University of Cambridge, Department of Pathology, Division of Virology, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Dymond T; Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Grainger K; Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Workman C; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Ferris M; Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Gkrania-Klotsas E; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Brown NM; Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Weekes MP; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Baker S; Public Health England Clinical Microbiology and Public Health Laboratory, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Peacock SJ; University of Cambridge, Department of Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Goodfellow IG; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom.
  • Gouliouris T; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.
  • de Angelis D; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom.
  • Török ME; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Elife ; 102021 08 24.
Article in English | MEDLINE | ID: covidwho-1371047
ABSTRACT
SARS-CoV-2 is notable both for its rapid spread, and for the heterogeneity of its patterns of transmission, with multiple published incidences of superspreading behaviour. Here, we applied a novel network reconstruction algorithm to infer patterns of viral transmission occurring between patients and health care workers (HCWs) in the largest clusters of COVID-19 infection identified during the first wave of the epidemic at Cambridge University Hospitals NHS Foundation Trust, UK. Based upon dates of individuals reporting symptoms, recorded individual locations, and viral genome sequence data, we show an uneven pattern of transmission between individuals, with patients being much more likely to be infected by other patients than by HCWs. Further, the data were consistent with a pattern of superspreading, whereby 21% of individuals caused 80% of transmission events. Our study provides a detailed retrospective analysis of nosocomial SARS-CoV-2 transmission, and sheds light on the need for intensive and pervasive infection control procedures.
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, presents a global public health challenge. Hospitals have been at the forefront of this battle, treating large numbers of sick patients over several waves of infection. Finding ways to manage the spread of the virus in hospitals is key to protecting vulnerable patients and workers, while keeping hospitals running, but to generate effective infection control, researchers must understand how SARS-CoV-2 spreads. A range of factors make studying the transmission of SARS-CoV-2 in hospitals tricky. For instance, some people do not present any symptoms, and, amongst those who do, it can be difficult to determine whether they caught the virus in the hospital or somewhere else. However, comparing the genetic information of the SARS-CoV-2 virus from different people in a hospital could allow scientists to understand how it spreads. Samples of the genetic material of SARS-CoV-2 can be obtained by swabbing infected individuals. If the genetic sequences of two samples are very different, it is unlikely that the individuals who provided the samples transmitted the virus to one another. Illingworth, Hamilton et al. used this information, along with other data about how SARS-CoV-2 is transmitted, to develop an algorithm that can determine how the virus spreads from person to person in different hospital wards. To build their algorithm, Illingworth, Hamilton et al. collected SARS-CoV-2 genetic data from patients and staff in a hospital, and combined it with information about how SARS-CoV-2 spreads and how these people moved in the hospital . The algorithm showed that, for the most part, patients were infected by other patients (20 out of 22 cases), while staff were infected equally by patients and staff. By further probing these data, Illingworth, Hamilton et al. revealed that 80% of hospital-acquired infections were caused by a group of just 21% of individuals in the study, identifying a 'superspreader' pattern. These findings may help to inform SARS-CoV-2 infection control measures to reduce spread within hospitals, and could potentially be used to improve infection control in other contexts.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Disease Outbreaks / COVID-19 / Hospitals Type of study: Observational study Limits: Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: ELife.67308

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Disease Outbreaks / COVID-19 / Hospitals Type of study: Observational study Limits: Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: ELife.67308